Belarus' Healthcare Minister Dmitry Pinevich is in talks with Chinese companies about the supply and joint production of medicines, as well as the purchase of equipment for healthcare facilities, BelTA learned from the press service of the Healthcare Ministry of Belarus.
Deal signed with China-571033 daily-sun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daily-sun.com Daily Mail and Mail on Sunday newspapers.
SARAJEVO, Jan. 22 (Xinhua) China Sinopharm International Corporation, a wholly-owned subsidiary of Sinopharm (China National Pharmaceutical Group Corporation), has donated a batch of epidemic prevention supplies to a hospital in Bosnia and Herzegovina (BiH), according to the Chinese Embassy on Friday. The donation ceremony was held Thursday at the Sveti Apostol Luka Hospital in Doboj, an ancient city in the Republika Srpska (RS), one of the two entities in BiH, according to the embassy. The company handed over 36 boxes of anti-epidemic supplies, including protective suits and surgical masks, to the hospital, a representative of China Sinopharm International Corporation Central Eastern Europe Branch told Xinhua.
By Ionut Arghire on December 10, 2020
The Russia-linked cyberspy group known as Zebrocy has adopted COVID-19 vaccine-related lures in a recently observed phishing campaign, threat detection and response company Intezer reported on Wednesday.
Initially detailed in 2018, Zebrocy is believed to be associated with the infamous Russian state-sponsored hacking group Sofacy (also tracked as APT28, Fancy Bear, Pawn Storm, Sednit, and Strontium).
In September 2020, QuoINT security researchers revealed that Zebrocy attacks on countries associated with the North Atlantic Treaty Organization (NATO) had continued. One month later, the United States Cyber Command (USCYBERCOM) shared new malware samples associated with the group.
In November, Intezer’s security researchers observed Zebrocy phishing emails carrying lure documents about Chinese pharmaceutical company Sinopharm International Corporation, which has reached phase three clinical trials for a COVID-19 vaccine.